This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC, a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1860, the company has a rich history marked by significant milestones, including its integration into the larger pharmaceutical landscape through mergers and acquisitions. Wyeth operates primarily in the biopharmaceutical sector, focusing on innovative treatments in areas such as immunology, oncology, and vaccines. The company is renowned for its core products, which include advanced biologics and specialty pharmaceuticals that address critical health needs. Wyeth's commitment to research and development has positioned it as a leader in the market, with notable achievements in vaccine development and chronic disease management. With a strong presence in North America and Europe, Wyeth Pharmaceuticals continues to make strides in improving patient outcomes and advancing healthcare solutions.
DitchCarbon Score
How does Wyeth Pharmaceuticals LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wyeth Pharmaceuticals LLC's score of 84 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Wyeth Pharmaceuticals LLC, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Pfizer Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. Pfizer Inc. has established various climate initiatives, including Science-Based Targets Initiative (SBTi) commitments, which are cascaded down to Wyeth Pharmaceuticals. However, specific reduction targets or achievements for Wyeth are not detailed in the available information. As part of its corporate family, Wyeth Pharmaceuticals is aligned with Pfizer's broader sustainability goals, which include commitments to reduce greenhouse gas emissions across all scopes. The absence of direct emissions data for Wyeth suggests a reliance on Pfizer's overarching strategies and targets to guide its climate actions. In summary, while Wyeth Pharmaceuticals LLC does not present specific emissions figures or reduction targets, it is positioned within Pfizer's climate framework, which aims to address carbon emissions and promote sustainability across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | - | - | - |
| Scope 2 | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | - | - | - |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wyeth Pharmaceuticals LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
